Astrana Health Q3 revenue up 37% to $478.7M; net income down 27% to $16.1M

Astrana Health, Inc.

2024-Q3 EPS reported $1.04 revenue$1,369,331,000

Q3 net income $16.1M (-27% YoY); diluted EPS $0.33 (-30%); adjusted EBITDA $45.2M (-13%).
Care Partners revenue $455.8M (+42% YoY); total revenue $478.7M (+37%).
Closed acquisition of Collaborative Health Systems for $37.5M plus up to $21.5M earnout on Oct 4.
FY2024 guidance raised: revenue $1.95B-$2.03B, adjusted EBITDA $165M-$175M, EPS $1.06-$1.19.
Nine-month revenue $1.37B (+32%); net income $50.1M (+4%); adjusted EBITDA $135.3M (+15%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.